EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant: Amsterdam, The Netherlands Monday, May 19, 2025, 10:00 Hrs [IST] European Medicines Agency’s (EMA ...

The European drugs regulator said on Thursday its safety panel has confirmed suicidal thoughts as a side effect of ...

Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries ...

According to analysts, the Fed is unlikely to cut interest rates this year.

Valneva (VALN) stock slips as the EU drug regulator suspends chikungunya vaccine for adults 65+ over safety concerns. Read ...

The medicine will remain on the shelves but will come with additional warnings about the side effects, which appear to be ...

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes The Paediatric Committee (PDCO) of the European Medicines Agency issues positive opinion on PolTREG’s ...

The inspection was conducted by the Finnish Medicines Agency on behalf of EMA from March 10 to March 14 and it concluded with ...

The EU drug regulator confirms suicidal ideation as a side effect of finasteride marketed by Organon (OGN) as Proscar for ...

Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...

The European Medicines Agency (EMA) has approved Moleculin Biotech’s clinical trial application (CTA) for a pivotal, ...

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...